Synopsis Diabetic retinopathy is a vision-threatening, microvascular complication of diabetes. It is also considered as the leading cause of blindness in working-age adults. Lipid-lowering therapies have previously been found to have a positive role in controlling diabetic retinopathy. However, it is unknown if statin therapy can delay or avert the development of diabetic retinopathy in patients with type 2 diabetes mellitus (T2DM) and dyslipidemia.
This week’s “ MED FACT ” discusses a population-based cohort study from JAMA Ophthalmology, ‘ Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy ’, Jan 2019. Authors : Kang EY, Chen TH, Garg SJ, et al. Key Takeaways : Statin therapy was associated with a reduced risk of diabetic retinopathy in patients with type 2 diabetes and dyslipidemia. Objective: To determine if there is any association between…
